株探米国株
英語
エドガーで原本を確認する
0001109138--12-31falseQ220232023-06-30IL

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
 
For the Month of September 2023
 
CAMTEK LTD.
(Translation of Registrant’s Name into English)
 
Ramat Gavriel Industrial Zone
P.O. Box 544
Migdal Haemek 23150
ISRAEL
(Address of Principal Corporate Offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F ☒    Form 40-F ☐
 
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities and Exchange Act of 1934.
 
Yes ☐    No ☒
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. This Form 6-K, including all exhibits hereto, is hereby incorporated by reference into all effective registration statements filed by the registrant under the Securities Act of 1933.
 
   
CAMTEK LTD.
(Registrant)
 
By: /s/ Moshe Eisenberg
——————————————
Moshe Eisenberg,
Chief Financial Officer

Dated: September 27, 2023
 
 
Exhibit
Number
Description of Exhibit
 
 
101
The following financial information from Camtek Ltd.’s Report on Form 6-K, formatted in XBRL (eXtensible Business Reporting Language): (i) Unaudited interim condensed consolidated balance sheets on June 30, 2023 and December 31, 2022; (ii) Unaudited interim condensed consolidated statements of operations for the six months ended June 30, 2023 and 2022 and the year ended December 31, 2022; (iii) Unaudited interim condensed consolidated statements of changes in shareholders’ equity for the six months ended June 30, 2023 and 2022 and the year ended December 31, 2022; (iv) Unaudited interim condensed consolidated statements of cash flows for the six months ended June 30, 2023 and 2022 and the year ended December 31, 2022; and (v) notes to the Unaudited interim condensed consolidated financial statements.
 

Represents an amount less than $1,000 Including shipping and handling costs Including foreign currency expense resulting from transactions not denominated in U.S. Dollars 0001109138 2023-01-01 2023-06-30 0001109138camt:PriortechLtdMember 2023-06-30 0001109138camt:ChromaAteIncMember 2023-06-30 0001109138currency:USD 2023-06-30 0001109138currency:USD 2022-12-31 0001109138currency:ILS 2023-06-30 0001109138currency:ILS 2022-12-31 0001109138currency:XXX 2023-06-30 0001109138currency:XXX 2022-12-31 0001109138 2023-06-30 0001109138 2022-12-31 0001109138us-gaap:LandMember 2023-06-30 0001109138us-gaap:BuildingMember 2023-06-30 0001109138us-gaap:MachineryAndEquipmentMember 2023-06-30 0001109138us-gaap:OfficeEquipmentMember 2023-06-30 0001109138us-gaap:ComputerEquipmentMember 2023-06-30 0001109138us-gaap:AutomobilesMember 2023-06-30 0001109138us-gaap:LeaseholdImprovementsMember 2023-06-30 0001109138camt:RightOfUseAssetsMember 2023-06-30 0001109138us-gaap:LandMember 2022-12-31 0001109138us-gaap:BuildingMember 2022-12-31 0001109138us-gaap:MachineryAndEquipmentMember 2022-12-31 0001109138us-gaap:OfficeEquipmentMember 2022-12-31 0001109138us-gaap:ComputerEquipmentMember 2022-12-31 0001109138us-gaap:AutomobilesMember 2022-12-31 0001109138us-gaap:LeaseholdImprovementsMember 2022-12-31 0001109138camt:RightOfUseAssetsMember 2022-12-31 0001109138 2021-12-31 0001109138 2022-06-30 0001109138 2022-01-01 2022-12-31 0001109138 2022-01-01 2022-06-30 0001109138us-gaap:CommonStockMember 2021-12-31 0001109138us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001109138us-gaap:RetainedEarningsMember 2021-12-31 0001109138us-gaap:RetainedEarningsMember 2023-06-30 0001109138us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001109138us-gaap:CommonStockMember 2023-06-30 0001109138us-gaap:RetainedEarningsMember 2022-06-30 0001109138us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001109138us-gaap:CommonStockMember 2022-06-30 0001109138us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001109138us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001109138us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001109138us-gaap:CommonStockMember 2022-07-01 2022-12-31 0001109138us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001109138us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-12-31 0001109138 2022-07-01 2022-12-31 0001109138us-gaap:RetainedEarningsMember 2022-07-01 2022-12-31 0001109138us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001109138us-gaap:TreasuryStockCommonMember 2022-01-01 2022-06-30 0001109138us-gaap:TreasuryStockCommonMember 2022-06-30 0001109138us-gaap:TreasuryStockCommonMember 2022-07-01 2022-12-31 0001109138us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0001109138us-gaap:TreasuryStockCommonMember 2023-06-30 0001109138us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001109138us-gaap:TreasuryStockCommonMember 2022-12-31 0001109138us-gaap:TreasuryStockCommonMember 2021-12-31 0001109138us-gaap:CommonStockMember 2022-12-31 0001109138us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001109138us-gaap:RetainedEarningsMember 2022-12-31 0001109138us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001109138us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001109138us-gaap:SubsequentEventMembercamt:FormfactorIncMember 2023-09-01 2023-09-18 iso4217:ILSxbrli:shares xbrli:pure xbrli:shares iso4217:USD iso4217:USDxbrli:shares

Exhibit 99.1

 

Camtek Ltd.
and its Subsidiaries

 

Interim Condensed Consolidated
Financial Statements
As of June 30, 2023
(Unaudited)
 

Camtek Ltd. and its Subsidiaries
 

Interim Unaudited Condensed Consolidated Financial Statements as at June 30, 2023


 
Contents
 
Interim Unaudited Condensed Consolidated Balance Sheets

 
         
June 30,
   
December 31,
 
         
2023
   
2022
 
   
Note
   
U.S. Dollars (in thousands)
 
Assets
                 
                   
Current assets
                 
Cash and cash equivalents
 
4A
 
   
232,787
     
148,156
 
Short-term deposits
         
198,500
     
251,500
 
Trade accounts receivable
         
79,025
     
80,611
 
Inventories
 
4B
 
   
61,207
     
65,541
 
Other current assets
 
4C
 
   
14,998
     
11,156
 
                       
Total current assets
         
586,517
     
556,964
 
                       
Long term deposits
         
75,000
     
79,000
 
Long term inventory
 
4B
 
   
7,125
     
5,357
 
Deferred tax assets
         
724
     
1,004
 
Other assets
         
2,557
     
1,024
 
Property, plant and equipment, net
 
4D
 
   
37,131
     
33,141
 
Intangible assets, net
 
4E
 
   
602
     
597
 
                       
Total non-current assets
         
123,139
     
120,123
 
                       
Total assets
         
709,656
     
677,087
 
                       
Liabilities and shareholders’ equity
                     
                       
Current liabilities
                     
Trade accounts payable
         
31,238
     
31,667
 
Other current liabilities
 
4F
 
   
45,529
     
56,833
 
                       
Total current liabilities
         
76,767
     
88,500
 
                       
Long term liabilities
                     
Other long-term liabilities
         
10,198
     
8,748
 
Convertible notes
 

4G

     
196,284
     
195,737
 
           
206,482
     
204,485
 
                       
Total liabilities
         
283,249
     
292,985
 
                       
Shareholders’ equity
                     
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at June 30, 2023 and at December 31, 2022;
                     
46,811,504 issued shares at June 30, 2023 and 46,505,318 at December 31, 2022;
                     
44,719,128 shares outstanding at June 30, 2023 and 44,412,942 at December 31, 2022;
 
3
     
175
     
175
 
Additional paid-in capital
         
193,626
     
187,105
 
Retained earnings
         
234,504
     
198,720
 
           
428,305
     
386,000
 
Treasury stock, at cost (2,092,376 shares as of June 30, 2023 and December 31, 2022)
         
(1,898
)
   
(1,898
)
                       
Total shareholders' equity
         
426,407
     
384,102
 
                       
Total liabilities and shareholders' equity
         
709,656
     
677,087
 
 
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.
 

F - 3


Camtek Ltd. and its Subsidiaries

 

Interim Unaudited Condensed Consolidated Statements of Operations
(In thousands, except per share data)
 
         
Six months ended
June 30,
   
Year ended
December 31,
 
         
2023
   
2022
   
2022
 
   
Note
   
U.S. dollars
   
U.S. dollars
 
Revenues
         
146,215
     
156,744
     
320,909
 
Cost of revenues
         
77,378
     
76,693
     
161,053
 
                               
Gross profit
         
68,837
     
80,051
     
159,856
 
                               
Research and development costs
         
15,672
     
15,199
     
28,859
 
Selling, general and
 administrative expenses
 
5A
     
24,037
     
24,451
     
49,499
 
           
39,709
     
39,650
     
78,358
 
                               
Operating income
         
29,128
     
40,401
     
81,498
 
                               
Financial income, net
 
5B
 
   
10,864
     
860
     
6,690
 
                               
Income before income taxes
         
39,992
     
41,261
     
88,188
 
                               
Income tax expense
         
(4,208
)
   
(3,700
)
   
(8,239
)
                               
Net income
         
35,784
     
37,561
     
79,949
 

 

F - 4


Camtek Ltd. and its Subsidiaries

 

Interim Unaudited Condensed Consolidated Statements of Operations (contd.)
 
Net income per ordinary share:
 
         
Six months ended
June 30,
   
Year ended
December 31,
 
         
2023
   
2022
   
2022
 
   
Note
   
U.S. dollars
   
U.S. dollars
 
                         
Basic net earnings per share
         
0.80
     
0.86
     
1.81
 
                               
Diluted net earnings per share
         
0.74
     
0.78
     
1.66
 
                               
Weighted average number of ordinary shares outstanding
  (in thousands):
                             
                               
Basic
         
44,562
     
43,929
     
44,158
 
                               
Diluted
         
48,531
     
48,150
     
48,229
 
 
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.
 

F - 5


Camtek Ltd. and its Subsidiaries

 

Interim Unaudited Condensed Consolidated Statements of Shareholders’ Equity


 
   
Ordinary Shares
   
Number of
         
Additional
         
Total
 
   
NIS 0.01 par value
   
Treasury
   
Treasury
   
paid-in
   
Retained
   
shareholders'
 
   
Number of
   
U.S. Dollars
   
Shares
   
Shares
   
earnings
   
earnings
   
equity
 
   
Shares Issued
   
(in thousands)
         
U.S. Dollars (in thousands)
 
Balances at
                                         
December 31, 2021
   
45,939,019
     
172
     
(2,092,376
)
   
(1,898
)
   
176,582
     
118,771
     
293,627
 
                                                         
Share-based
                                                       
 compensation
                                                       
 expense
   
-
     
-
     
-
     
-
     
5,592
     
-
     
5,592
 
Exercise of share
                                                       
 options and RSUs
   
416,840
     
2
     
-
     
-
     
-
     
-
     
2
 
Net income
   
-
     
-
     
-
     
-
     
-
     
37,561
     
37,561
 
                                                         
Balances at
                                                       
June 30, 2022
   
46,355,859
     
174
     
(2,092,376
)
   
(1,898
)
   
182,174
     
156,332
     
336,782
 
                                                         
Share-based
                                                       
 compensation
                                                       
 expense
   
-
     
-
     
-
     
-
     
4,931
     
-
     
4,931
 
Exercise of share
                                                       
 options and RSUs
   
149,459
     
1
     
-
     
-
     
-
     
-
     
1
 
Net income
   
-
     
-
     
-
     
-
     
-
     
42,388
     
42,388
 
Balances at
                                                       
 December 31, 2022
   
46,505,318
     
175
     
(2,092,376
)
   
(1,898
)
   
187,105
     
198,720
     
384,102
 
                                                         
Share-based
                                                       
 compensation
                                                       
 expense
   
-
     
-
     
-
     
-
     
6,521
     
-
     
6,521
 
Exercise of share
                                                       
 options and RSUs
   
306,186
     
*
     
-
     
-
     
-
     
-
     
-
 
Net income
   
-
     
-
     
-
     
-
     
-
     
35,784
     
35,784
 
                                                         
Balances at
                                                       
June 30, 2023
   
46,811,504
     
175
     
(2,092,376
)
   
(1,898
)
   
193,626
     
234,504
     
426,407
 
 
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.
 
*Represents an amount less than $1,000

 

F - 6


Camtek Ltd. and its Subsidiaries

 

Interim Unaudited Condensed Consolidated Statements of Cash Flows
(In thousands)
 
   
Six months ended
June 30,
   
Year ended
December 31,
 
   
2023
   
2022
   
2022
 
   
U.S. dollars
   
U.S. dollars
 
Cash flows from operating activities:
                 
Net income
   
35,784
     
37,561
     
79,949
 
Adjustments to reconcile net income to net
                       
cash provided by operating activities:
                       
Depreciation and amortization
   
2,406
     
1,849
     
4,094
 
Deferred tax expense
   
280
     
110
     
(777
)
Amortization of debt issuance costs
   
547
     
547
     
1,094
 
Loss on disposal of fixed assets
   
233
     
-
     
-
 
Share based compensation expense
   
6,521
     
5,592
     
10,523
 
Change in provision for doubtful debts
   
-
     
-
     
(7
)
                         
Changes in operating assets and liabilities:
                       
Trade accounts receivable
   
1,829
     
(14,252
)
   
(21,984
)
Inventories
   
171
     
(13,512
)
   
(9,518
)
Due from related parties
   
-
     
(2
)
   
-
 
Other assets
   
(5,375
)
   
(2,079
)
   
(6,337
)
Trade accounts payable
   
(231
)
   
1,244
     
(2,113
)
Other current liabilities
   
(9,449
)
   
(4,111
)
   
2,875
 
                         
  Net cash provided by operating activities
   
32,716
     
12,947
     
57,799
 
                         
Cash flows from investing activities:
                       
Redemption (investment) of short-term deposits
   
57,000
     
(179,000
)
   
(95,500
)
Investment of long-term deposits
   
-
     
(15,000
)
   
(47,000
)
Purchase of fixed assets
   
(4,782
)
   
(3,786
)
   
(8,197
)
Purchase of intangible assets
   
(60
)
   
(28
)
   
(97
)
                         
Net cash provided by (used in) investing activities
   
52,158
     
(197,814
)
   
(150,794
)
 
Cash flows from financing activities:
                 
Proceeds from exercise of share options
   
-
     
2
     
3
 
                         
Net cash provided by financing activities
   
-
     
2
     
3
 
Effect of change in exchange rate on cash and cash equivalents
   
(243
)
   
(1,037
)
   
(795
)
                         
Net increase (decrease) in cash and cash equivalents
   
84,631
     
(185,902
)
   
(93,787
)
Cash and cash equivalents at beginning of the period
   
148,156
     
241,943
     
241,943
 
                         
Cash and cash equivalents at end of the period
   
232,787
     
56,041
     
148,156
 

 

F - 7


Camtek Ltd. and its Subsidiaries

 

Interim Unaudited Condensed Consolidated Statements of Cash Flows

(In thousands)
 
   
Six months ended
June 30,
   
Year ended
December 31,
 
   
2023
   
2022
   
2022
 
   
U.S. dollars
   
U.S. dollars
 
Supplementary cash flows information:
                 
Income taxes paid
   
9,626
     
454
     
11,836
 
Interest received
   
6,911
     
1,030
     
4,293
 
Lease payments
   
735
     
689
     
1,480
 
                         
Non-cash transactions:
                       
Fixed assets purchased with supplier credit
   
371
     
680
     
569
 

 

The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.

 

F - 8


Camtek Ltd. and its Subsidiaries

 

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)
Note 1 - Nature of Operations
 
  A.
Camtek Ltd. (“Camtek” or the “Company”), an Israeli corporation, is jointly controlled 21.5% by Priortech Ltd., an Israeli corporation listed on the Tel-Aviv Stock Exchange and 17.5% by Chroma Ate Inc., a Taiwanese company (“Chroma”). Camtek provides automated and technologically advanced solutions dedicated to enhancing production processes, increasing product yield and reliability, and enabling and supporting customers’ latest technologies in the semiconductor fabrication industry.

 

 

F - 9


Camtek Ltd. and its Subsidiaries

 

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

Note 2 - Basis of Preparation
 
A.          Statement of compliance
 
Except as described below, the accounting policies applied in these interim financial statements are the same as those applied in the Company’s 2022 annual audited consolidated financial statement for the year ended December 31, 2022.
 
The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and do not include all of the information required for full annual financial statements. The unaudited condensed consolidated interim statements should be read in conjunction with the Company’s 2022 annual audited consolidated financial statements and footnotes, which were filed with the U.S. Securities and Exchange Commission as part of the Company’s Annual Report on Form 20-F for the year ended December 31, 2022.
 
In the opinion of management of the Company, the accompanying unaudited condensed financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2023, and its results of operations for the three months and nine months ended June 30, 2023, and 2022, and cash flows for the six months ended June 30, 2023, and 2022. The condensed balance sheet at December 31, 2022, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements.

 

 

F - 10


Camtek Ltd. and its Subsidiaries

 

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

Note 3 - Shareholders’ Equity
 
A.          General
 
The Company’s shares are traded on the NASDAQ Global Market under the symbol “CAMT”, and also listed and traded on the Tel-Aviv stock exchange
 
B.          Changes in Stock Options and RSUs
 
The number of stock options exercised in the six-month period ended June 30, 2023, was 306,186.
 
In the first six months of 2023, 509,231 restricted share units (RSUs) were granted by the Company. The RSUs vest over a four-year period.
 
C.          Share-based Compensation Expense
 

The total share-based compensation expense amounted to $6,521, $5,592, and $10,523 for the six-month periods ended June 30, 2023 and 2022 and the year ended December 31, 2022, respectively.

 

 

F - 11


Camtek Ltd. and its Subsidiaries

 

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

Note 4 - Supplementary Financial Statements Information
 
A.          Cash and cash equivalents
 
The Company’s cash and cash equivalent balance at June 30, 2023 and December 31, 2022 is denominated in the following currencies:
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
U.S. Dollars (in thousands)
 
US Dollars
   
226,172
     
139,644
 
New Israeli Shekels
   
4,416
     
4,008
 
Other currencies
   
2,199
     
4,504
 
                 
     
232,787
     
148,156
 
 
Short-term deposits are bank deposits in US Dollars with terms at the investment date of 3-12 months with average annual interest rates of 5.05%.
 
B.          Inventories
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
U.S. Dollars (in thousands)
 
Components
   
34,158
     
43,017
 
Work in process
   
15,444
     
13,951
 
Finished products (including systems at customer locations not yet sold)
   
18,730
     
13,930
 
                 
     
68,332
     
70,898
 
 
Inventories are presented in:
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
U.S. Dollars (in thousands)
 
Current assets
   
61,207
     
65,541
 
Long-term assets
   
7,125
     
5,357
 
                 
     
68,332
     
70,898
 
 

 

F - 12


Camtek Ltd. and its Subsidiaries

 

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

Note 4 - Supplementary Financial Statements Information (cont’d)
 
C.          Other Current Assets
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
U.S. Dollars (in thousands)
 
             
Interest receivable
   
7,048
     
3,979
 
Prepaid expenses
   
4,315
     
3,832
 
Due from Government institutions
   
2,875
     
2,598
 
Other
   
760
     
747
 
                 
     
14,998
     
11,156
 
 
D.          Property, Plant and Equipment, Net
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
U.S. Dollars (in thousands)
 
Land
   
863
     
863
 
Building
   
20,345
     
18,490
 
Machinery and equipment
   
22,590
     
19,121
 
Office furniture and equipment
   
997
     
934
 
Computer equipment and software
   
6,218
     
6,256
 
Automobiles
   
396
     
396
 
Leasehold improvements
   
2,080
     
1,894
 
Right of use assets
   
5,845
     
6,087
 
     
59,334
     
54,041
 
                 
Less accumulated depreciation
   
22,203
     
20,900
 
                 
     
37,131
     
33,141
 
 

 

F - 13


Camtek Ltd. and its Subsidiaries

 

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

Note 4 - Supplementary Financial Statements Information (cont’d)

 
E.          Intangible Assets, Net
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
U.S. Dollars (in thousands)
 
Patent registration costs
   
2,195
     
2,135
 
                 
Accumulated amortization and impairment
   
1,593
     
1,538
 
                 
Total intangible assets, net
   
602
     
597
 
 
F.          Other Current Liabilities
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
U.S. Dollars (in thousands)
 
             
Commissions
   
18,789
     
18,048
 
Advances from customers and deferred revenues
   
7,199
     
12,825
 
Accrued employee compensation and related benefits
   
10,506
     
11,941
 
Accrued warranty costs (1)
   
3,041
     
3,161
 
Government institutions and income tax payable
   
2,844
     
7,991
 
Accrued expenses
   
1,884
     
1,570
 
Operating lease obligations
   
1,266
     
1,297
 
                 
 
   
45,529
     
56,833
 
 
(1)          Changes in the accrued warranty costs are as follows:
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
U.S. Dollars (in thousands)
 
             
Beginning of year
   
3,161
     
3,265
 
Accruals
   
2,721
     
5,823
 
Usage
   
(2,841
)
   
(5,927
)
                 
Balance at end of year
   
3,041
     
3,161
 
 

 

F - 14


Camtek Ltd. and its Subsidiaries

 

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

 

Note 4 - Supplementary Financial Statements Information (cont’d)
 
G.          Convertible Notes
 
The Convertible Senior Notes consisted of the following:
 
   
June 30,
   
December 31,
 
   
2023
   
2022
 
   
U.S. Dollars (in thousands)
 
Liability:
           
Principle:
   
200,000
     
200,000
 
Unamortized issuance costs
   
3,716
     
4,263
 
Net carrying amount
   
196,284
     
195,737
 
 
As of June 30, 2023, the debt issuance costs of the Notes will be amortized over the remaining term of approximately 3.5 years.
 
The annual effective interest rate of the Notes is 0.56%. In the six-months ended June 30, 2023, $547 was recorded as amortization of debt issuance costs (In the year ended December 31, 2022 - $1,094).
 
As of June 30, 2023, the estimated fair value of the Notes, which the Company has classified as Level 2 financial instruments, is $179,154 (December 31, 2022 - $152,565). The estimated fair value was determined based on the quoted bid price of the Notes in an over-the-counter market on the last trading day of the reporting period.
 
As of June 30, 2023, the principal amount exceeded the if-converted value of the Notes by $20,846 (December 31, 2022, the principal amount exceeded the if-converted value of the Notes by $47,435).

 

 

F - 15


Camtek Ltd. and its Subsidiaries

 

Notes to the Interim Unaudited Condensed Consolidated Financial Statements


(Amounts in thousands, except per share data)

Note 5 - Statements of Operations

 
A.
Selling, general and administrative expenses
 
   
Six months ended
June 30,
   
Year ended
December 31,
 
   
2023
   
2022
   
2022
 
   
U.S. Dollars (in thousands)
 
Selling (1)
   
17,910
     
18,840
     
38,249
 
General and administrative
   
6,127
     
5,611
     
11,250
 
                         
     
24,037
     
24,451
     
49,499
 
                         
(1)         Including shipping and handling costs
   
1,025
     
980
     
2,294
 
 
B.          Financial income (expenses), net
 
   
Six months ended
June 30,
   
Year ended
December 31,
 
   
2023
   
2022
   
2022
 
   
U.S. Dollars (in thousands)
 
Interest income
   
11,838
     
2,488
     
8,648
 
Amortization of issuance costs of convertible notes
   
(547
)
   
(547
)
   
(1,094
)
Other, net (1)
   
(427
)
   
(1,081
)
   
(864
)
                         
     
10,864
     
860
     
6,690
 
                         
(1)         Including foreign currency expense resulting from transactions not denominated in U.S. Dollars
   
(172
)
   
(871
)
   
(351
)
Note 6 – Subsequent Events
 
On September 18, 2023, the Company announced it has entered into an agreement to acquire the FRT Metrology business of FormFactor, Inc. The acquisition is expected to close during the fourth quarter of 2023, subject to the satisfaction of customary closing conditions. The purchase price is $100 million in cash, subject to customary purchase price adjustments.

 
F - 16
EX-99.2 3 exhibit_99-2.htm EXHIBIT 99.2

Exhibit 99.2

Operating and Financial Review and Prospects.
 
A.
Operating Results
 
General
 
The following discussion of our financial condition and results of operations should be read in conjunction with the consolidated financial statements and the notes to those statements included therein, which have been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP.
 
Overview
 
We design, develop, manufacture and market automated solutions dedicated for enhancing production processes and yield for the semiconductor fabrication market, principally based on core AOI technology.
 
We sell our systems worldwide. The vast majority of our sales are to manufacturers in the Asia Pacific region, including China, South East Asia, Korea and Taiwan, due to, among other factors, the migration of the electronic manufacturers into this region.
 
In the first half of 2023, our sales to customers in the Asia Pacific region accounted for approximately 86% of our total revenues with sales to China being 55% of our total revenues.
 
In addition to revenues derived from the sale of systems and related products, we generate revenues from providing maintenance and support services for our products. We generally provide a one-year warranty with our systems. Accordingly, service revenues are not earned during the warranty period.
 
Critical Accounting Policies
 
Critical accounting policies are those that are, in management’s view, most important to the portrayal of a company’s financial condition and results of operations and most demanding judgment calls, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. We believe our most critical accounting policies relate to:
 
Revenue Recognition. The Company’s contracts with its customers include performance obligations to provide its products or to service the installed products. A product sale contract may include an extended warranty (that is, for longer than the twelve-month standard warranty) as well as installation, both of which are considered separate performance obligations.
 

The Company recognizes revenue from contracts for sales of products when the Company transfers control of the product to the customer. This generally occurs upon shipment as pre-shipment calibration and testing processes ensure simplified and streamlined installation at the customer site. Revenues from the contract are recognized in an amount that reflects the consideration the Company expects to be entitled to receive once the product is operating in accordance with its specifications and signed documentation of the arrangement, such as a signed contract or purchase order, has been received. Payment terms with customers may vary, but are generally based on milestones within the delivery process such as shipping and installation. Payment terms do not include significant financing components.
 
The Company does not incur costs in obtaining a contract except for agents’ commissions, which are incurred upon the recognition of revenues. Revenues are recognized over a period of less than a year and as such, there are no underlying sales commissions to be capitalized.
 
Service revenues consist mainly of contracts charged under time and material arrangements. Service revenues from maintenance contracts are recognized ratably over the contract period.
 
Contracts with customers may include multiple performance obligations. For such arrangements, the Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged to customers.
 
The Company’s multiple performance obligations consist of product sales, installation services and non-standard warranties. A fixed amount is deferred in respect of installation services for machines that have been recognized but not installed as of the balance sheet date. A non-standard warranty is one that is for a period longer than 12 months. Accordingly, income from a non-standard warranty is deferred as unearned revenue and is recognized ratably as revenue commencing with and over the applicable warranty term.
 
The Company records contract liabilities when the customer has been billed in advance of the Company completing its performance obligations. These amounts are recorded as deferred revenue in the Consolidated Balance Sheets.
 
Valuation of Accounts Receivable.  We review accounts receivable to determine which are doubtful of collection. In making this determination of the appropriate allowance for doubtful accounts, we consider information at hand regarding specific customers, including aging of the receivable balance, evaluation of the security received from customers, our history of write-offs, relationships with our customers and the overall credit worthiness of our customers. Changes in the credit worthiness of our customers, the general economic environment and other factors may impact the level of our future write-offs.
 
Valuation of Inventory.  Inventories consist of completed systems, partially completed systems and components, and are recorded at the lower of cost, determined by the moving – average basis, or market. We review inventory for obsolescence and excess quantities to determine that items deemed obsolete or excess inventory are appropriately reserved. In making the determination, we consider forecasted future sales or service/maintenance of related products and the quantity of inventory at the balance sheet date, assessed against each inventory item’s past usage rates and future expected usage rates. Changes in factors such as technology, customer demand, competing products and other matters could affect the level of our obsolete and excess inventory in the future.
 


In the first half of 2023 there were no write-offs of inventory. In the year 2022 we wrote-off inventory in the amount of approximately $0.3 million. The write-off amounts are included in the line item called "Cost of products sold", in the consolidated statements of operations. The write-offs create a new cost basis and are a permanent reduction of inventory cost. The write-offs in in 2022 were made against damaged, obsolete, excess and slow-moving inventory. Inventory that is not expected to be converted or consumed in the following 12 months is classified as non-current. As of June 30, 2023, a $7.1 million portion of our inventory was classified as non-current. Management periodically evaluates our inventory composition, giving consideration to factors such as the probability and timing of anticipated usage and the physical condition of the items, and then estimates a charge (reducing the inventory) to be provided for slow moving, technologically obsolete or damaged inventory. These estimates could vary significantly from actual requirements based upon future economic conditions, customer inventory levels or competitive factors that were not foreseen or did not exist when the inventory write-offs were established.
 
Intangible assets. Patent registration costs are capitalized at cost and amortized, beginning with the first year of utilization, over its expected life of ten years.
 
We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the long lived asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized as computed by subtracting the fair market value of the asset from its carrying value.
 
Provisions for contingent liabilities. A contingency (provision) in accordance with ASC Topic 450-10-05, Contingencies, is an existing condition or situation involving uncertainty as to the range of possible loss to the entity. A provision for claims is recognized if it is probable (likely to occur) that a liability has been incurred and the amount can be estimated reasonably. Provisions in general are highly judgmental, especially in cases of legal disputes. We assess the probability of an adverse event and if the probability is evaluated to be probable, we are required to fully provide for the total amount of the estimated contingent liability. We continually evaluate our pending provisions to determine if accruals are required. It is often difficult to accurately estimate the ultimate outcome of a contingent liability. Different variables can affect the timing and amount we provide for certain contingent liabilities. Our assessments are therefore subject to estimates made by us and our legal counsel, adverse revision in our estimates of the potential liability could materially impact our financial condition, results of operations or liquidity.
 
Valuation of Long Lived Assets. We apply ASC Subtopic 360-10, "Property, Plant and Equipment".  This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of the long lived asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized as computed by subtracting the fair market value of the asset from its carrying value. We prepare future cash flows based on our best estimates including projections and financial statements, future plans and growth estimates.
 


Income Taxes. We account for income taxes under ASC Subtopic 740-10 Income Taxes – Overall.  Deferred tax assets or liabilities are recognized in respect of temporary differences between the tax bases of assets and liabilities and their financial reporting amounts as well as in respect of tax losses and other deductions which may be deductible for tax purposes in future years, based on tax rates applicable to the periods in which such deferred taxes will be realized. The rates applied are those enacted in law as of June 30, 2023. In assessing the realizability of deferred tax assets, we consider whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible and during which the carry-forwards are available. Valuation allowances are established when necessary to reduce deferred tax assets to the amount considered more likely than not to be realized.
 
Our financial statements include deferred tax assets, net, which are calculated according to the above methodology. If there is an unexpected critical deterioration in our operating results and forecasts, we would have to increase the valuation allowance with respect to those assets. We believe that it is more likely than not that those net deferred tax assets included in our financial statements will be realized in subsequent years.
 
Stock Option and Restricted Share Plans. We account for our employee stock-based compensation awards in accordance with ASC Topic 718, Compensation - Stock Compensation. ASC Topic 718 requires that all employee stock‑based compensation is recognized as a cost in the financial statements and that for equity-classified awards such cost is measured at the grant date fair value of the award. We estimate grant date fair value using the Black‑Scholes-Merton option‑pricing model. Forfeitures are recognized when they occur.    
 
Leases. On January 1, 2019, we adopted Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02) using the modified retrospective transition approach by applying the new standard to all leases existing at the date of initial application. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under Topic 842.
 
The adoption did not impact our beginning retained earnings, or prior year consolidated statements of income and statements of cash flows.
 
Under Topic 842, we determine if an arrangement is a lease at inception. ROU assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, we consider only payments that are fixed and determinable at the time of commencement. As most of our leases do not provide an implicit rate, we use its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate is a hypothetical rate based on its understanding of what our credit rating would be (7.0% in 2023). Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. When determining the probability of exercising such options, we consider contract-based, asset-based, entity-based, and market-based factors. Lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the consolidated statements of income. Our lease agreements generally do not contain any residual value guarantees or restrictive covenants.
 

Operating lease ROU assets are presented as property, plant and equipment on the consolidated balance sheet. The current portion of operating lease liabilities is included in other current liabilities and the long-term portion is presented within long-term liabilities on the consolidated balance sheet.
 
For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
 
ROU assets for operating leases are periodically reduced by impairment losses. We use the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment – Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.
 
Comparison of Period to Period Results of Operations
 
The following table presents consolidated statement of operations data for the periods indicated as a percentage of total revenues from continuing operations:
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
Revenues
   
100.0
%
   
100.0
%
Cost of revenues
   
52.9
%
   
48.9
%
Gross profit
   
47.1
%
   
51.1
%
Operating expenses:
               
Research and development, net
   
10.7
%
   
9.7
%
Selling, general and administrative expenses
   
16.4
%
   
15.6
%
Total operating expenses
   
27.2
%
   
25.3
%
Operating income
   
19.9
%
   
25.8
%
Financial income, net
   
7.4
%
   
0.5
%
Income tax (expenses) benefit
   
(2.9
)%
   
(2.4
)%
Net income
   
24.5
%
   
24.0
%


Six months Ended June 30, 2023 compared to Six months ended June 30, 2022
 
Revenues. Revenues decreased by 6.7% to $146.2 million in 2023 from $156.7 million in 2022. The increase is mainly due to the sale of a lower number of tools due to decreased demand in the semiconductor market.
 
Gross Profit. Gross profit consists of revenues less cost of revenues, which includes the cost of components, production materials, labor, service related expenses, depreciation, factory and overhead expenses and provisions for warranties. These expenditures are partially affected by sales volume. Our total gross profit decreased to $68.8 million in 2023 from $80.1 million in 2022, a decrease of $11.3 million, or 14%. Our gross margin reduced to 47.1% in 2023, compared to a gross margin of 51.1% in 2022.
 
Research and Development Costs. Research and development expenses consist primarily of salaries, materials consumption and costs associated with subcontracting certain development efforts. Total research and development expenses for 2023 increased to $15.7 million from $15.2 million in 2022 due to increased activity for improving capabilities and developing additional features and products.
 
Selling, General and Administrative Expenses. Selling, general and administrative expenses consist primarily of expenses associated with salaries, commissions, promotion and travel, professional services and rent costs. Our selling, general and administrative expenses decreased by 1.7% to $24.0 million in 2023 from $24.5 million in 2022, mainly due to a decrease in sales channels activity on decreased revenues.
 
Financial Income (Expenses), Net. Financial income/expenses consist of interest, revaluation and other bank fees. We had net financial income of $10.9 million in 2023, compared to net financial income of $0.9 million in 2022. These changes relate to interest income from higher interest rates on increased short- and long-term deposits, offset by losses from changes in the exchange rate.
 
Provision for Income Taxes. Income tax expense was $4.2 million in 2023 compared to expense of $3.7 million in 2022, mainly due to tax on increased financial income from increased cash and cash equivalents.
 
Net Income. We realized net income of $35.8 million in 2023 compared to net income of $37.6 million in 2022, in light of the factors discussed above.
 


B.
Liquidity and Capital Resources
 
Our cash and cash equivalent and short-term deposit balances totalled approximately $431.3 million on June 30, 2023 and $399.7 million on December 31, 2022. In addition, there was $75 million and $79 million, respectively, in long-term deposits. Our cash is invested in bank deposits spread among several banks, primarily in Israel.
 
Our working capital was approximately $509.8 million at June 30, 2023 and $468.5 million at December 31, 2022. The increase is mainly attributed to the increase in cash and cash equivalents and the decrease in other current liabilities, offset by the decrease in short-term deposits.
 
Our capital expenditures during the first half of 2023 were approximately $4.8 million, mainly in support of our operating activities.
 
Cash flow from operating activities
 
Net cash and cash equivalents provided by operating activities for the six months ended June 30, 2023, totalled $32.7 million. Net cash and cash equivalents provided by operating activities for the six months ended June 30, 2022 totalled $12.9 million.
 
During the first half of 2023, cash provided by operating activities was primarily attributed to the positive net income and the increase in trade accounts receivable, offset by the increase in other current assets and the decrease in other current liabilities.
 
Cash flow from investing activities
 
Cash flow used in investing activities in the first half of 2023 was $52.2 million, primarily due to the redemption of short- and long-term deposits, compared to $197.8 million in the first half of 2022.
 
Cash flow from financing activities
 
Cash flow provided by financing activities the first half of 2023 and 2022 was zero.